Advertising Health on FacebookAdvertising Health on FacebookAdvertising Health on TwitterAdvertising Health on TwitterFollow Advertising Health on Linked InFollow Advertising Health on Linked InInstagramInstagramPodcastsPodcasts

Advertising Health | Healthcare Advertising agency news and gossip

Promotions within senior team at HAVAS LYNX


HAVAS LYNX, has promoted three of their most valued senior team. Steph McCabe and Lisa Jeary have been appointed as Client Services Directors and Rob Fuller has been appointed Strategy Director.

David Hunt, HAVAS LYNX CEO commented:

“Steph, Lisa and Rob have each made an invaluable contribution to LYNX and our success to date. They have each built strong, talented teams and have helped HAVAS LYNX grow and adapt to an increasingly challenging environment. Their dedication and commitment will help ensure we achieve our business goals and, more importantly that we can continue to drive creativity and innovation that drives better patient outcomes.”

McCabe has been with the agency for nearly 10 years and has been instrumental in delivering exceptional creative campaigns across Europe collecting numerous industry awards. Steph led the Psoriasis360 campaign to drive patient awareness which was the first true social media campaign within healthcare.

Jeary has been with the agency for 4 years and has worked on many of LYNXs award winning campaigns. Lisa has delivered outstanding campaigns across Europe, Asia, and the States covering a wide range of therapy areas including mental health, immunisation and cardiology to name a few. Lisa is currently leading the team to deliver innovative digital academy for sales representatives in Japan utilising gamification.

Fuller has had a significant impact shaping and growing the agencies insights and planning offering, driving strategic excellence across the business. Rob brings his intellect, creativity, insight and passion to bear across many of the agencies key accounts. He is currently leading the strategy team for the agencies latest global client, Novartis.